Dr. Steven L Kanter M.D.

Recommended Articles

• New Diagnostic Tool Approved for Lymphoma

  A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...

• The Link Between Lymphoma Radiotherapy and Mesothelioma

  One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...

• How is Multiple Myeloma Diagnosed?

  Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...

• 'Robocop' Stem Cells Developed to Fight Cancer

  Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...

• Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research

  There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...